Reversible post-translational modification by poly(ADP-ribose) (PAR) regulates chromatin structure, DNA repair and cell fate in response to genotoxic stress. PAR glycohydrolase (PARG) removes PAR chains from poly(ADP-ribose)ylated proteins to restore protein function and release oligo(ADP-ribose) chains to signal damage. Here we report crystal structures of mammalian PARG and its complex with a substrate mimic that reveal an open substrate-binding site and a unique 'tyrosine clasp' enabling endoglycosidic cleavage of branched PAR chains.
PARG catalyzes the removal of PAR chains from post-translationally modified proteins by hydrolysis of α(1′′-2′) O-glycosidic linkages, functioning as an endoglycosidase to release oligo(ADP-ribose) and as an exoglycosidase to release ADP-ribose 1, 2 . Long PAR polymers are efficiently hydrolyzed (K m = ~1 µM) by a combination of endo-and exoglycosidic activity 3 , whereas smaller digestion products are poor substrates for PARG (K m > 10 µM), allowing oligo(ADP-ribose) chains to accumulate and function as ligands for histones and for damage-signaling and repair proteins such as p53 and XRCC1 (ref. 4) .
PARG comprises an N-terminal regulatory and targeting domain (A-domain; residues 1-456 in the rat protein), a central mitochondrial targeting sequence (MTS; residues 457-472) and a C-terminal catalytic domain (residues 473-972) 5 . The A-domain is required for recruitment of PARG to DNA damage sites 6 , and mice expressing a PARG isoform lacking the A-domain are hypersensitive to genotoxic stress 5 . This smaller isoform has constitutively high enzymatic activity 7 and retains the MTS, which is essential for PARG activity in vitro 8 . These findings suggest that the A-domain regulates PARG activity and/or its recruitment to substrates and that the MTS has a more direct role in the enzymatic activity of PARG.
To better understand PARG enzymatic functions and their potential for regulation, we determined a 1.95-Å crystal structure of rat PARG (rPARG 385 ; residues 385-972) lacking the poorly structured A-domain, which does not contribute to PARG activity in vitro 8 , and the structure of rPARG 385 bound to the transition-state analog ADP-HPD 9 (Fig. 1, Supplementary Figs. 1-3 and Supplementary Table 1 ). The rPARG 385 catalytic domain adopts a bean-shaped structure with a deep central cleft containing the conserved PARG signature motif (GGG-X 6-8 -QEE) 10 and Tyr791, which contributes strongly to PARG catalytic efficiency and inhibitor binding 11 (Fig. 1) . The structure consists of a α-β-α fold with a nine-stranded, mixed β-sheet flanked by several layers of α-helices ( Fig. 1a and Supplementary Fig. 4a ). The active site cleft lies on one edge of the β-sheet, and an extended N-terminal segment containing the MTS wraps around the other edge of the β-sheet, contributing to the PARG catalytic domain (Fig. 1) . The core of rPARG 385 resembles a canonical macrodomain found in ADP-ribose binding proteins, but the rPARG 385 fold is more elaborate than that of other macrodomain structures previously reported [12] [13] [14] [15] ( Fig. 1 and Supplementary Fig. 4) , including that of a bacterial PARG from Thermomonospora curvata 14 . The core structure of rPARG 385 closely resembles the bacterial PARG homolog (Dali 16 Z score = 16.5, r.m.s. deviation = 3.2 Å for 208 Cα atoms) with many of the catalytic residues superimposing well ( Fig. 2a) , which predicts that the catalytic mechanisms of PARG are similar across these organisms. However, there are substantial differences between the shapes of the substrate-binding site in mammalian and bacterial glycohydrolases, including a structural element unique to the former that we have named the tyrosine clasp (Tyr clasp) ( Figs. 1 and 2) .
The conserved macrodomain topology centers on a sevenstranded sheet 12, 14 (strand order 1-2-7-6-3-5-4; Supplementary Figs. 2 and 4a), with five conserved α-helices of the macrodomain fold (H1-H5) being inserted in the connections between strands where they pack against either side of the β-sheet. These helices and connecting loops include the majority of residues participating in the ADP-ribose binding 12 , deacetylase 15 and glycohydrolase activities 14 of different macrodomains. The rPARG 385 macrodomain lacks strand S1 but has three additional β-strands (β2, β5 and β6) adjacent to strand S4 that expand the width of the sheet and provide additional surface for helices α1-α6 to pack against ( Fig. 1a and Supplementary Fig. 4a ). These additional structural elements contributed by residues located between the MTS and the macrodomain core of rPARG 385 pack against one face of the central β-sheet, forming a bean-shaped structure and accounting for nearly one-third of the residues in the catalytic domain. The helical bundle comprising α1-α6 has no structural homologs in the Protein Data Bank. Helices α10-α14, located in the C-terminal half of the catalytic domain, pack against the opposite face of the β-sheet to complete the fold. The N-and C-terminal helical bundles of PARG form the boundaries of a broad cleft that contains the active site ( Fig. 1a) and may b r i e F c o m m u n i c at i o n s contribute to specialized functions of mammalian PARG proteins, including a substrate preference for long PAR polymers 3 .
The ADP-HPD inhibitor is a tight-binding mimic of ADP-ribose 9 that was crystallized in the PARG active site ( Fig. 2 and Supplementary  Fig. 3 ). The pyrrolidine ring of ADP-HPD mimics the positively charged oxocarbenium ion of the transition state for glycosidase reactions 17 and is positioned similarly in the rat PARG and T. curvata glycohydrolase structures (Fig. 2) . The catalytic residue Glu752 (refs. 10,14) lies proximal to the anomeric C1′ position ( Fig. 2b) , where it could function as a general acid or base to protonate the 2′-OH of the ribose′ leaving group and then activate water for nucleophilic attack. A water molecule close to Glu752 in the unliganded rPARG 385 structure is in a position compatible with a nucleophilic attack of the ribose′′ C1′ of a PAR substrate ( Supplementary Fig. 5a,b) , as proposed for a similarly positioned water in the T. curvata glycohydrolase structure 14 (Supplementary Fig. 5c ). The PARG signature motif (GGG-X 6-8 -GEE) 10 extends from the glycine-rich loop and precisely orients the catalytic Glu752 toward the scissile O-glycosidic bond of the ribose′′ moiety ( Supplementary Fig. 4b ). Two neighboring main chain nitrogen atoms from Gly742 and Val749 form hydrogen bonds to the side chain of Glu752 (Fig. 2b) . This microenvironment may shift the effective pK a of Glu752 to enable protonation of the leaving group as the first step of the proposed mechanism ( Supplementary  Fig. 5d ). The orientation of Glu752 relative to the substrate analog in the crystal structure could support a water attack from either side of the ribose ring, generating either the ADP-α-ribose′′ (retaining mechanism) or the ADP-β-ribose′′ (inverting mechanism) ( Supplementary Fig. 5d ).
The orientation of ADP-HPD is similar in rPARG 385 and T. curvata glycohydrolases ( Fig. 2a) , but the adenine ring and pyrrolidine substituents are more solvent accessible in rPARG 385 . This open architecture may facilitate endoglycohydrolase activity at internal sites of irregularly branching PAR chains. The Tyr clasp and residues in the adenine-binding pocket make additional contacts to the adenylate moiety of ADP-HPD ( Fig. 2a and Supplementary Fig. 2 ) that may compensate for the comparatively exposed and unencumbered binding of the proximal ribose′. The Tyr clasp forms a β-hairpin (β10 and β11) with an apical Tyr791 pointing into the substrate-binding cleft where it can cross-link to a photoaffinity conjugate of ADP-HPD 11 . Besides stacking with the adenine ring, the protruding Tyr791 side chain also forms a hydrogen bond with O5′ of the diphosphate of ADP-HPD ( Fig. 2b) . These interactions provide a structural rationale for the observed 95% reduction in affinity for ADP-HPD in the bovine mutant equivalent to Y791A in the rat enzyme 11 . Notably, the intricate interactions between rPARG 385 and the substrate analog impart the correct binding register with the enzyme and reinforce proper alignment for catalysis.
The MTS proposed to function in mitochondrial import of PARG 18 is also required for enzymatic activity in vitro, despite its distant Thirty-five residues preceding and including the MTS traverse more than 80 Å, taking an L-shaped path along the outer surface of the rPARG 385 catalytic domain (Fig. 1) . In this extended conformation, the MTS buttresses helix α7 and the base of the Tyr clasp (Fig. 1c) .
These interactions include a hydrogen bond between the main chain nitrogen atom of Met460 and the Gly728 main chain carbonyl on a loop following α7. Pro461 is within van der Waals contact distance of the Cys814 side chain of the Tyr clasp. Two conserved leucine residues (Leu467 and Leu470) pack against Trp810 side chain of the Tyr clasp ( Fig. 1c) . Deletion of the MTS or mutation of the conserved leucine residues would remove an anchor point and potentially destabilize helix α7 and the Tyr clasp, unraveling the adenine-binding pocket and explaining the loss of enzymatic activity caused by this truncation 8 .
The adjacent A-domain is proposed to regulate PARG activity 7, 10 and is connected to the catalytic domain by an extended, solvent-exposed linker incorporating the MTS motif. Protein interactions or posttranslational modifications of the A-domain might alter this connection to the catalytic domain and change enzymatic activity. At the opposite end of the substrate-binding channel, rPARG 385 makes extensive contacts with the adenine ring. Recognition of the adenine base is accomplished by α7 and the Tyr clasp (Fig. 2b) . A total of seven residues (Tyr788 and Tyr791 from the Tyr clasp; Thr721, Ile722 and Glu723 from α7; Gln750 from α8; and Phe898) interact with the adenine ring, explaining the binding selectivity for adenine nucleosides 1, 19 . Both side chain dihedral angles of Phe898 rotate approximately 180° relative to the unliganded enzyme position, opening the pocket to allow the adenine ring to bind while positioning the phenylalanine side chain for an edge-stacking π-π interaction with the ligand. Similar perpendicular π-π stacking is observed between the side chains of Tyr791 and Phe734 and the adenine moiety. Substitution of Tyr791 with tryptophan does not markedly affect catalytic activity 11 , revealing the importance of stacking interactions with the Tyr clasp's namesake tyrosine residue. The chemical identity of the adenine base is read out by hydrogen bonds between the side chain of Glu723 and N6, and the backbone nitrogen of Ile722 and N1 (Fig. 2b) .
Mammalian PARG functions as both an endo-and exoglycohydrolase, rapidly cleaving PAR polymers internally into oligo(ADP-ribose) chains that are slowly hydrolyzed by an inefficient exoglycohydrolase activity, whereas the T. curvata glycohydrolase is proposed to function exclusively as an exoglycohydrolase, cleaving the PAR-chain termini to generate ADP-ribose 14 . The substantially expanded structure of mammalian PARG in comparison to other macrodomains is probably relevant to PARG's substrate preference for large polymers of ADPribose 3 . The grooves extending from the ADP-HPD binding site are attractive candidates for additional interactions (Fig. 3) that support endoglycohydrolase activity and the production of oligo(ADP-ribose) chains functioning in damage signaling 20 and regulation of chromatin structure 4 . Structural comparison of the ADP-HPD complexes of rPARG 385 and the T. curvata glycohydrolase reveals that Arg268 of the bacterial enzyme caps the 2′-OH group of adenosine ribose, effectively blocking access to internal glycosidic linkages of the PAR polymer 14 (Fig. 3a,b) . The position of Arg268 is reinforced by an ion pair with Asp261 in the loop connecting conserved S7 and H5 (S7-H5 loop), a hydrogen bond to the main chain carbonyl of Cys224 and multiple van der Waals contacts 14 . This matrix of interactions readily explains why the bacterial enzyme is an obligate exoglycohydrolase.
By contrast, α12 of rPARG 385 , corresponding to the C-terminal helix H5 of the conserved macrodomain fold, is rotated ~20° and translated ~5 Å with respect to the corresponding helix of the bacterial glycohydrolase (Fig. 3b) . These distinctive packing arrangements resemble the movement of the analogous C-terminal helix in the histone macroH2A1.1, which is triggered by binding to ADP-ribose and completely masks the 2′-OH group of adenosine ribose 13 . Consequently, this alternative conformation of α12 exposes the 2′-OH group of adenosine ribose, giving rise to an open platform that accommodates binding of an additional ADP-ribose molecule ((n+1) ADP-ribose) and is consistent with this enzyme's ability to bind and cleave internal sites of PAR chains (Fig. 3b,c) . Computational simulations of di-ADP-ribose binding reveal an unencumbered substrate-binding site, suggesting that additional electrostatic interactions with the phosphate backbone of PAR chains help to secure substrates for cleavage ( Fig. 3c) . npg Our collective results provide what are, to our knowledge, the first crystal structures of mammalian PARG and its complex with a substrate mimic, revealing unique functional elements in mammalian PARG that provide an exciting opportunity for the rational design of inhibitors for use in biology and medicine.
MetHoDs
Methods and any associated references are available in the online version of the paper. 
oNLINe MetHoDs
Protein purification and crystallization and data collection. Rat PARG (residues 385-972) was expressed from pET28a (Novagen) with an N-terminal his-tag in Escherichia coli BL21 expressing GroESL chaperone in the presence of 0.5 M urea. The protein was purified by affinity capture on a Ni-NTA (Qiagen) column. After elution with imidazole, the protein was loaded onto a heparin column and eluted with a salt gradient (0-1M NaCl). Finally, the protein was applied to a Superdex 200 (GE Healthcare) size-exclusion column. Selenomethionine-labeled rPARG 385 protein was purified by the same protocol as the native protein. Native and selenium-containing proteins were concentrated to 15 mg ml −1 in 25 mM HEPES (pH 7.5), 150 mM NaCl, 5% glycerol and 2 mM DTT and then stored at −80 °C. Crystals were grown by hangingdrop vapor diffusion. The protein solution was mixed with an equal volume of well solution (16- Supplementary Table 1 .
Structure determination. The apo rPARG 385 structure was determined by MAD (multiple-wavelength anomalous diffraction) phasing of a selenomethionine protein derivative. X-ray data were processed using HKL2000 (ref. 21 ) and SCALEPACK 21, 22 . Nine selenium sites were located by the automated Patterson searches implemented in SOLVE 23 . Experimentally phased maps had a well-defined solvent boundary and readily interpretable electron density for protein. The crystallographic model was constructed using COOT 24 and refined with TLS constraints in REFMAC 25 . The apo PARG 385 structure was refined to a crystallographic R factor = 18.0% and R free = 21.6%. The N-terminal 53 residues (residues 385-437) and C-terminal 14 residues (959-972) were disordered. The PARG-ADP-HPD complex structure was solved by molecular replacement using CNS 26 with the apo PARG 385 structure as a search model. The asymmetric unit contains three PARG molecules, and they all show a strong electron density for ADP-HPD. The model was built using COOT 24 with refinement in REFMAC. The structure was refined to an R factor = 24.5% and an R free = 27.5%. Crystallographic data statistics are shown in Supplementary Table 1 . 100% (apo rPARG 385 ) and 99.4% (rPARG 385 -ADP-HPD complex) of all residues are in the favored and allowed region of the Ramachandran plot. All structural figures were prepared using PyMOL (http://www.pymol.org/). PARG activity assay. ARG activity was measured against PARylated PARP1. PARylation of PARP1 was performed at 30 °C in 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10 mM MgCl 2 and 2 mM DTT. To PARylate PARP1, PARP1 375-1,014 (2 µM), the DNA-binding domain (residues 1-374) (1 µM) and a nicked DNA (2 µM) were pre-incubated for 10 min on ice 27 . NAD + (200 µM) was then added to the reaction, and the mixture was incubated at 30 °C for 30 min. The reaction was quenched by adding 80 mM nicotinamide. Different concentrations of purified PARG proteins were then treated to PARylated PARP1 and incubated for 30 min at 30 °C. The level of modification of PARP1 was visualized by SDS-PAGE (Supplementary Fig. 1 ).
Computational simulations of poly(ADP-ribose).
Conformational sampling of an ADP-ribose dimer model was used to predict binding sites for the (n+1) ADP-ribose moiety while the adjacent (n) ADP-ribose group at the binding site for the ADP-HPD ligand was fixed. The ADP-ribose dimer was generated by splicing an ADP-ribose molecule onto the 2´-OH group of the adenosine ribose´ moiety of the ADP-HPD inhibitor. The MindRocket modeling package (Drug Design Methodologies, LLC) was then used to perform an exhaustive search of chemically reasonable conformations of the ADP-ribose tail to identify favorable binding sites on the rPARG 385 surface nearby. The search consisted of 11 rotatable bonds and was constrained within 8 Å of the protein surface to prevent unnecessary sampling out in solvent 28 . Docking poses were scored using a modified potential function based upon the VALIDATE scoring function 27 . The search was performed after scaling the van der Waals radii (scale factor = 0.85) to allow more complete sampling, especially near the junction between the ribose moieties. The side chains of rPARG 385 were fixed during the search, which generated approximately two million conformers of the ADP-ribose moiety. The top 5,000 structures were minimized using the TRIPOS Force Field 28 and visually clustered into three conformational families where the ADPR tail could reside. Three representative low-energy conformers of the (n+1) ADP-ribose shown in Figure 3c exhibit diverse binding modes for the diphosphate and adenosine moieties, and no specific binding pocket was identified for (n+1) ADP-ribose. These results suggest that internal cleavage of PAR polymers is accommodated by conformationally unrestrictive, electrostatic interactions with PAR's phosphoribose backbone at sites flanking the enzyme active site.
